These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 11487480)

  • 1. CFTR and pseudomonas infections in cystic fibrosis.
    Tatterson LE; Poschet JF; Firoved A; Skidmore J; Deretic V
    Front Biosci; 2001 Aug; 6():D890-7. PubMed ID: 11487480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How mutant CFTR may contribute to Pseudomonas aeruginosa infection in cystic fibrosis.
    Pier GB; Grout M; Zaidi TS; Goldberg JB
    Am J Respir Crit Care Med; 1996 Oct; 154(4 Pt 2):S175-82. PubMed ID: 8876538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transgenic cystic fibrosis mice exhibit reduced early clearance of Pseudomonas aeruginosa from the respiratory tract.
    Schroeder TH; Reiniger N; Meluleni G; Grout M; Coleman FT; Pier GB
    J Immunol; 2001 Jun; 166(12):7410-8. PubMed ID: 11390493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innate lung defenses and compromised Pseudomonas aeruginosa clearance in the malnourished mouse model of respiratory infections in cystic fibrosis.
    Yu H; Nasr SZ; Deretic V
    Infect Immun; 2000 Apr; 68(4):2142-7. PubMed ID: 10722612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the CFTR in susceptibility to Pseudomonas aeruginosa infections in cystic fibrosis.
    Goldberg JB; Pier GB
    Trends Microbiol; 2000 Nov; 8(11):514-20. PubMed ID: 11121762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of mutant CFTR in hypersusceptibility of cystic fibrosis patients to lung infections.
    Pier GB; Grout M; Zaidi TS; Olsen JC; Johnson LG; Yankaskas JR; Goldberg JB
    Science; 1996 Jan; 271(5245):64-7. PubMed ID: 8539601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deleterious impact of Pseudomonas aeruginosa on cystic fibrosis transmembrane conductance regulator function and rescue in airway epithelial cells.
    Trinh NT; Bilodeau C; Maillé É; Ruffin M; Quintal MC; Desrosiers MY; Rousseau S; Brochiero E
    Eur Respir J; 2015 Jun; 45(6):1590-602. PubMed ID: 25792634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of CFTR protein susceptibility to bacterial infections in cystic fibrosis.
    Ramphal R
    Trends Microbiol; 2001 Feb; 9(2):63. PubMed ID: 11286194
    [No Abstract]   [Full Text] [Related]  

  • 9. Inflammation in cystic fibrosis airways: relationship to increased bacterial adherence.
    Scheid P; Kempster L; Griesenbach U; Davies JC; Dewar A; Weber PP; Colledge WH; Evans MJ; Geddes DM; Alton EW
    Eur Respir J; 2001 Jan; 17(1):27-35. PubMed ID: 11307750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mouse models of chronic lung infection with Pseudomonas aeruginosa: models for the study of cystic fibrosis.
    Stotland PK; Radzioch D; Stevenson MM
    Pediatr Pulmonol; 2000 Nov; 30(5):413-24. PubMed ID: 11064433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basic science for the chest physician: Pseudomonas aeruginosa and the cystic fibrosis airway.
    Williams HD; Davies JC
    Thorax; 2012 May; 67(5):465-7. PubMed ID: 22382597
    [No Abstract]   [Full Text] [Related]  

  • 12. Microbial ecology and adaptation in cystic fibrosis airways.
    Yang L; Jelsbak L; Molin S
    Environ Microbiol; 2011 Jul; 13(7):1682-9. PubMed ID: 21429065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Harnessing Neutrophil Survival Mechanisms during Chronic Infection by
    Marteyn BS; Burgel PR; Meijer L; Witko-Sarsat V
    Front Cell Infect Microbiol; 2017; 7():243. PubMed ID: 28713772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asialo GM1 is a receptor for Pseudomonas aeruginosa adherence to regenerating respiratory epithelial cells.
    de Bentzmann S; Roger P; Dupuit F; Bajolet-Laudinat O; Fuchey C; Plotkowski MC; Puchelle E
    Infect Immun; 1996 May; 64(5):1582-8. PubMed ID: 8613364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrinsic and environmental mutagenesis drive diversification and persistence of Pseudomonas aeruginosa in chronic lung infections.
    Rodríguez-Rojas A; Oliver A; Blázquez J
    J Infect Dis; 2012 Jan; 205(1):121-7. PubMed ID: 22080096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the cystic fibrosis transmembrane conductance regulator in internalization of Pseudomonas aeruginosa by polarized respiratory epithelial cells.
    Darling KE; Dewar A; Evans TJ
    Cell Microbiol; 2004 Jun; 6(6):521-33. PubMed ID: 15104594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cysteamine re-establishes the clearance of Pseudomonas aeruginosa by macrophages bearing the cystic fibrosis-relevant F508del-CFTR mutation.
    Ferrari E; Monzani R; Villella VR; Esposito S; Saluzzo F; Rossin F; D'Eletto M; Tosco A; De Gregorio F; Izzo V; Maiuri MC; Kroemer G; Raia V; Maiuri L
    Cell Death Dis; 2017 Jan; 8(1):e2544. PubMed ID: 28079883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CFTR negatively regulates cyclooxygenase-2-PGE(2) positive feedback loop in inflammation.
    Chen J; Jiang XH; Chen H; Guo JH; Tsang LL; Yu MK; Xu WM; Chan HC
    J Cell Physiol; 2012 Jun; 227(6):2759-66. PubMed ID: 21913191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Airway epithelial control of Pseudomonas aeruginosa infection in cystic fibrosis.
    Campodónico VL; Gadjeva M; Paradis-Bleau C; Uluer A; Pier GB
    Trends Mol Med; 2008 Mar; 14(3):120-33. PubMed ID: 18262467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CFTR mutations and host susceptibility to Pseudomonas aeruginosa lung infection.
    Pier GB
    Curr Opin Microbiol; 2002 Feb; 5(1):81-6. PubMed ID: 11834374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.